FMC-376 CL101

An Open-label, Phase 1/2 Dose-Escalation, Dose Expansion and Cohort Expansion Study Evaluating the Safety, Pharmacokinetics and Clinical Activity of FMC-XXX in Participants with KRAS G12C Mutated Locally Advanced Unresectable or Metastatic Solid Tumors.

Enquire

Trial overview

Clinical Area

Medical Oncology

Disease

Basket

Disease site

Basket

Study Phase

Phase I

Trial Identifiers

Registration number: NCT06244771

https://clinicaltrials.gov/study/NCT06244771

GenesisCare Location(s)

South Terrace (Medical Oncology & Haematology)

St Andrew’s Medical Centre, Level 1, 321 South Terrace, Adelaide, SA, 5000, Australia

08 8463 2500

reception@aoah.com.au

Find out more Get directions

Principal Investigator(s)

Medical Oncologist

Dr Vy Broadbridge

MBBS FRACP

View Profile

Clinical trials enquiries

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.

First name *

Last name *

Email *

Phone *

State *

Postcode *

What is the reason for enquiry?

How would you prefer to be contacted? *

Phone

By submitting you acknowledge we will use the information you are providing to contact you about your enquiry. For more information about how we handle your personal information, please refer to the GenesisCare Privacy Policy.

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.

Disclaimer: